Oxford Performance Materials Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Oxford Performance Materials Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011279
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxford Performance Materials Inc (OPMI), a subsidiary of Arkema Inc is a chemical company that manufactures thermoplastic polymers. The company’s products include proprietary polyether ketone ketone formulations, additives, complex assemblies, biomedical raw materials, biomedical parts, robotics hardware, industrial parts, and MRI and CR scanning and imaging products. It offers biocompatible materials, biomedical devices, patient specific cranial and facial devices, cranioplasty fixation systems, and others. OPMI also provides vertebral body replacement systems, supplemental fixation systems, implants, mold release, fluids, solvents, and layer by layer building devices. The company offers proprietary performance PEKK polymer formulations, laser sintering systems, polymers, industrial and aerospace components, and others. It serves biomedical, orthopedics, and aerospace industries. OPMI is headquartered in South Windsor, Connecticut, the US.

Oxford Performance Materials Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oxford Performance Materials Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Oxford Performance Materials Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Oxford Performance Materials Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Oxford Performance Materials Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Oxford Performance Materials Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Oxford Performance Materials Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Oxford Performance Materials Secures US$1.2 Million In Venture Financing 10
Partnerships 11
RTI Surgical Enters into Licensing Agreement with Oxford Performance Materials 11
Biomet Microfixation Enters Into Distribution Agreement With Oxford Performance Materials For OsteoFab Cranial Implants 12
Oxford Performance Materials Inc – Key Competitors 13
Oxford Performance Materials Inc – Key Employees 14
Oxford Performance Materials Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
Dec 05, 2017: Antibacterial Benefits of PEKK for Orthopedic Applications Detailed in Study of 3D-Printed OsteoFab Structures 16
Aug 08, 2017: Oxford Performance Materials Announces Commercial Launch of OXPEKK Custom Compounds 17
Mar 13, 2017: European Patent Granted for OsteoFab Implants 18
Mar 13, 2017: Oxford Performance Materials: European Patent Granted for OsteoFab Implants 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Oxford Performance Materials Inc, Medical Equipment, Key Facts 2
Oxford Performance Materials Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Oxford Performance Materials Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Oxford Performance Materials Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Oxford Performance Materials Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Oxford Performance Materials Inc, Deals By Market, 2011 to YTD 2017 8
Oxford Performance Materials Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Oxford Performance Materials Secures US$1.2 Million In Venture Financing 10
RTI Surgical Enters into Licensing Agreement with Oxford Performance Materials 11
Biomet Microfixation Enters Into Distribution Agreement With Oxford Performance Materials For OsteoFab Cranial Implants 12
Oxford Performance Materials Inc, Key Competitors 13
Oxford Performance Materials Inc, Key Employees 14

★海外企業調査レポート[Oxford Performance Materials Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mangalore Chemicals & Fertilizers Ltd (MANGCHEFER):企業の財務・戦略的SWOT分析
    Summary Mangalore Chemicals & Fertilizers Ltd (MCFL), a subsidiary of Zuari Fertilisers and Chemicals Ltd, is a chemical company that manufactures and markets fertilizers, plant nutrition products, and plant protection chemicals. The company offers urea, di-ammonium phosphate, granulated fertilizers …
  • Jet Airways (India) Ltd.:企業の戦略・SWOT・財務情報
    Jet Airways (India) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Jet Airways (India) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kinnov Therapeutics SAS-製薬・医療分野:企業M&A・提携分析
    Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company’s pipeline product include KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic receptors …
  • Cre8tek Ltd (FGO):石油・ガス:M&Aディール及び事業提携情報
    Summary Cre8tek Ltd (Cre8tek), formerly Marion Energy Ltd, is an oil and gas exploration and production company. The company explores, acquires, develops, produces and markets oil and gas. It has core operations in Clear Creek field located in the Uinta Basin. Cre8tek also holds interest in the addi …
  • The Menarini Group:企業のM&A・事業提携・投資動向
    The Menarini Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Menarini Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • LifeAssays AB (LIFE B):医療機器:M&Aディール及び事業提携情報
    Summary LifeAssays AB (LifeAssays) is a medical device company that develops, manufactures and markets in-vitro diagnostic and veterinary care products. The company offers point-of-care diagnostic testing systems. It provides product portfolio such as lifeassays human system and lifeassays veterinar …
  • Precision System Science Co Ltd (7707):医療機器:M&Aディール及び事業提携情報
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company provide products such as automated nucleic acid isolation system, large sample volume nucleic acid extract …
  • Votorantim Energia Ltda.:企業の戦略的SWOT分析
    Votorantim Energia Ltda. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Medicenna Therapeutics Corp (MDNA)-製薬・医療分野:企業M&A・提携分析
    Summary Medicenna Therapeutics Corp (Medicenna) formerly known as A2 Acquisition Corp, is a clinical stage, immuno-oncology company which provides novel first-in-class and interleukin-4 empowered cytokines. The Company's products under development include MDNA55, MDNA56, MDNA57, fully human interleu …
  • Hindustan Petroleum Corporation Limited:企業の戦略・SWOT・財務分析
    Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Cree, Inc.:戦略・SWOT・企業財務分析
    Cree, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cree, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Minoryx Therapeutics sl:製薬・医療:M&Aディール及び事業提携情報
    Summary Minoryx Therapeutics sl (Minoryx) is a clinical stage biotechnology company that develops treatments for life threatening rare diseases. The company offers discovery, preclinical research, development and clinical trial programs. It develops ALD-MIN, morquio B and PCT drugs used for lysosoma …
  • AB Sciex LLC:医療機器:M&Aディール及び事業提携情報
    Summary AB Sciex LLC (Sciex), a subsidiary of Danaher Corp, is a provider of life science analytical technologies. The company provides mass spectrometry solutions combined with capillary electrophoresis and liquid chromatography. Its product portfolio includes liquid chromatography-mass spectromete …
  • ManpowerGroup Inc (MAN):企業の財務・戦略的SWOT分析
    ManpowerGroup Inc (MAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Healthscope Ltd:企業の戦略的SWOT分析
    Healthscope Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Imbalie Beauty Limited:企業の戦略・SWOT・財務情報
    Imbalie Beauty Limited - Strategy, SWOT and Corporate Finance Report Summary Imbalie Beauty Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Imuraya Group Co., Ltd.:企業の戦略・SWOT・財務分析
    Imuraya Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Imuraya Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Alnylam Pharmaceuticals Inc (ALNY)-製薬・医療分野:企業M&A・提携分析
    Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiova …
  • Talktalk Telecom Group PLC (TALK):企業の戦略的SWOT分析
    Talktalk Telecom Group PLC (TALK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆